vimarsana.com

Page 4 - தலைமை விஞ்ஞானி சௌமிய சுவாமிநாதன் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

India s virus cases lower but WHO expert says positive tests ominously high

India s virus cases lower but WHO expert says positive tests ominously high Reuters 2 hrs ago NEW DELHI, May 17 (Reuters) - India on Monday reported a further decline in new coronavirus cases though daily deaths remained above 4,000 and experts warned that the count was unreliable due to a lack of testing in rural areas, where the virus is spreading fast. For months now, nowhere in the world has been hit harder than India by the pandemic, as a new strain of the virus first found there fuelled a surge in infections that has risen to more than 400,000 daily. Even with a downturn over the past few days, experts said there was no certainty that infections had peaked, with alarm growing both at home and abroad over the new more contagious B.1.617 variant taking hold.

11 May 2021 Coronavirus Charts and News: How To Return To Work And Keep Getting The $300 Unemployment Benefit COVID Found In Penile Tissue Could Contribute To ED

Written by Steven HansenThe U.S. new cases 7-day rolling average are 21.2 % LOWER than the 7-day rolling average one week ago and U.S. deaths due to coronavirus are now 11.1 % LOWER than the rolling average one week ago. Today s posts include:

WHO strongly supports TRIPS waiver, not time to worry about patents, profits: Chief Scientist Swaminathan

WHO strongly supports TRIPS waiver, not time to worry about patents, profits: Chief Scientist Swaminathan ANI | Updated: May 11, 2021 05:00 IST By Reena Bhardwaj Geneva [Switzerland], May 11 (ANI): World Health Organisation (WHO) Chief Scientist Soumya Swaminathan on Monday (local time) said that the global health body strongly believes that Trade-Related Aspects of Intellectual Property Rights (TRIPS) waiver to COVID-19 vaccines at the World Trade Organisation (WTO) should be done. In an exclusive interview with ANI, Swaminathan said: WHO strongly believes that the TRIPS waiver that has been proposed by India and South Africa should be done. DG Tedros has often spoken about this. This is not the time to worry about patents and profits amid the pandemic.

WHO Chief Scientist says India s COVID-19 figures worrying, calls for exercises to report actual numbers

World Health Organisation (WHO) Chief Scientist Soumya Swaminathan speaking to ANI on Monday (local time) WHO Chief Scientist says India s COVID-19 figures worrying, calls for exercises to report actual numbers By Reena Bhardwaj | Updated: May 11, 2021 05:00 IST Geneva [Switzerland], May 11 (ANI): As India is in the grasp of a devastating second wave of COVID-19, World Health Organisation (WHO) Chief ScientistSoumya Swaminathan on Monday (local time) termed the rate of infections and deaths in the country as worrying and called on governments to boost exercises on reporting actual numbers. In an exclusive interview with ANI, Swaminathan said that the projections of one million deaths by August projected by the Institute for Health Metrics and Evaluation (IHME) are based on models and available data, which are not predictions of the future and can be changed.

WHO strongly supports TRIPS waiver on COVID-19 vaccines

WHO strongly supports TRIPS waiver on COVID-19 vaccines ANI 11 May 2021, 09:55 GMT+10 By Reena BhardwajGeneva [Switzerland], May 11 (ANI): World Health Organisation (WHO) Chief Scientist Soumya Swaminathan on Monday (local time) said that the global health body strongly believes that Trade-Related Aspects of Intellectual Property Rights (TRIPS) waiver to COVID-19 vaccines at the World Trade Organisation (WTO) should be done. In an exclusive interview with ANI, Swaminathan said: WHO strongly believes that the TRIPS waiver that has been proposed by India and South Africa should be done. DG Tedros has often spoken about this. This is not the time to worry about patents and profits amid the pandemic. In October last year, India and South Africa, along with 57 members of WTO proposed a waiver from certain provisions of the TRIPS agreement for prevention, containment, and treatment of COVID-19.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.